文章摘要

参考文献/References

［1］ Yang W, Ahn H, Hinrichs M, et al. Evidence of a novel isoform of placenta growth factor (PGF4) expressed in human trophoblast and endothelial cells［J］. J Reprod Immunol, 2003, 60(1):53-60.

［2］张海宏，张玉成，曾智. 胎盘生长因子与心血管疾病中的血管生成［J］．心脏杂志， 2005， 17（6）：610-612．

［3］ Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia［J］. N Engl J Med, 2004, 350(7):672-683.

［4］ Thadhani R, Mutter WP, Wolf M, et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and for preeclampsia［J］. J Clin Endocrinol Metab, 2004, 89(2):770-775.

［5］ Cho GJ, Roh GS, Kim HJ, et al. Differential expression of placenta growth factors and their receptors in the normal and pregnancy induced hypertensive human placentas［J］. J Korean Med Sci, 2003, 18(3):402-408.

［6］ Oura H, Bertoncini J, Velasco P, et al. A critical role of placental growth factor in the induction of inflammation and edema formation［J］. Blood, 2003, 101(2):560-567.

［7］ Khurana R, Moons L, Shafi S, et al. Placental growth factor promotes atherosclerosis intimal thickening and macrophage accumulation［J］. Circulation, 2005, 111(21):2828-2836.

［8］ Pilarczyk K, Sattler KJ, Galili O, et al. Placenta growth factor expression in human atherosclerotic carotid plaques is related to plaque destabilization［J］. Atherosclerosis, 2008, 196(1):333-340.

［9］ Iwama H, Uemura S, Naya N, et al. Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction［J］. J Am Coll Cardiol, 2006, 47(8):1559-1567.

［10］V S, Eggermann J, Dunaeva M, et al. Enhanced functional response of CD133+ circulating progenitor cells in patients early after acute myocardial infarction［J］. Eur Heart J, 2008, 29(2):241-250.

［11］Heeschen C, Dimmeler S, Fichtlscherer S, et al. Prognostic value of placental growth factor in patients with acute chest pain［J］. JAMA, 2004, 291(4):435-441.

［12］Lenderink T, Heeschen C, Fichtlscherer S, et al. Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes［J］. J Am Coll Cardiol, 2006, 47(2):307-311.

［13］Apple FS, Pearce LA, Chung A, et al. Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome［J］. Clin Chem, 2007, 53(5):874-881.

［14］Kolakowski S Jr, Berry MF, Atluri P, et al. Placental growth factor provides a novel local angiogenic therapy for ischemic cardiomyopathy［J］. J Card Surg, 2006, 21(6):559-564.

［15］Lambiase PD, Edwards RJ, Anthopoulos P, et al. Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support［J］. Circulation, 2004, 109(24):2986-2992.

［16］Werner GS, Jandt E, Andreas K. Growth factors in the collateral circulation of chronic total coronary occlusions relation to duration of occlusion and collateral function［J］. Circulation, 2004, 110(14):1940-1945.

［17］Briguori C, Testa U, Colombo A, et al. Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals［J］. Am J Cardiol, 2006, 97(4):472-476.

［18］Kodama Y, Kitta Y, Nakamura T, et al. Atorvastatin increase plasma soluble Fms-like tyrosine kinase-1 and decrease vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction［J］. J Am Coll Cardiol, 2006, 48(1):43-50.

［19］Autiero M, Waltenberger J, Communi D, et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1［J］. Nat Med, 2003, 9(7):936-943.

我们的网站为什么显示成这样？

胎盘生长因子的生物学功能及其与心血管疾病的关系

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

文章信息/Info

参考文献/References

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics